Join our CEO Sarah Boyce, CMO Steve Hughes, and CSTO Mike Flanagan tomorrow at 8:00am ET for a #firesidechat during the Wells Fargo Healthcare Conference to learn more about the exciting progress we are making with our three clinical programs for #DM1, #DMD44 and #FSHD. To view the webcast, visit: https://lnkd.in/grNtBgD
Avidity Biosciences, Inc.
Biotechnology
San Diego, California 16,565 followers
At Avidity, we are developing a new class of oligonucleotide-based therapies.
About us
DELIVERING ON OUR VISION Our vision is to profoundly improve people’s lives by revolutionizing the delivery of RNA therapeutics. We’re utilizing our proprietary AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs) with the precision of oligonucleotide-based therapies in order to redefine RNA therapeutics and more effectively target underlying genetic drivers of diseases. We are delivering on this vision by investing in our platform, our pipeline and our people. Through this platform, we are pleased to share our ideas and company progress as we advance our science and overall mission to deliver breakthrough therapies to patients.
- Website
-
http://www.aviditybiosciences.com
External link for Avidity Biosciences, Inc.
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- San Diego, California
- Type
- Public Company
- Founded
- 2013
- Specialties
- drug discovery and development, nucleic acids, RNA, and rare disease
Locations
-
Primary
10578 Science Center Dr
Suite 125
San Diego, California 92121, US
Employees at Avidity Biosciences, Inc.
Updates
-
Today we celebrate #LaborDay and honor the hard work and dedication of people who drive progress in our communities. Wishing you a safe and enjoyable holiday.
-
-
Meet Anna Monterastelli, our summer intern in #RegulatoryAffairs. Anna will soon receive her M.S. in biomedical sciences from Charles R. Drew University. She discovered Avidity through their Biomedical Sciences Enrichment Program, where she recognized her potential to make a significant impact in the #biopharmaceutical industry. She’s excited to apply her knowledge in her role and is inspired by the personable team and welcoming environment she found at Avidity. Learn more about our work at Avidity at https://lnkd.in/dH-56XKM #BeAVID
-
-
Meet Vivian Nguyen, our summer #Chemistry intern. Vivian is currently majoring in pharmacological chemistry with a minor in general #biology at UC San Diego. Since joining our internship program, she’s been inspired by our welcoming, supportive team and is eager to apply the skills she’s gained to her future career in the #biopharma industry. Learn more about our work at Avidity at https://lnkd.in/eevGCqR6 #BeAVID
-
-
Tomorrow during the 3rd Annual Oligonucleotide CMC & Analytical Development Summit in Boston, our Associate Director of Analytical Development, Matthew McQueen, will deliver a presentation at 9:30am ET exploring the critical aspects of comparability studies for various oligonucleotide structures and best practices for effective life cycle management. We look forward to joining industry leaders, analytical development professionals, and CMC experts to exchange insights on standardized approaches. Check out the agenda for more details: https://lnkd.in/e7nSy7_W
-
-
We are proud to support Life Science Cares San Diego to help disrupt the cycle of poverty and inequality in the San Diego community. Last month, we welcomed students to Avidity from the Monarch School, the only public community school that exclusively nurtures the development of unhoused students in San Diego. Students had the opportunity to meet with our team to learn more about the #lifesciences industry and the many career opportunities it holds. By partnering with Life Science Cares and supporting the Monarch School and Project Onramp, we aim to make a meaningful difference in the San Diego community and foster the next generation of leaders. To learn more about our partnership with Life Science Cares, watch this video: https://lnkd.in/eTJtcSdh
We are excited to share that we’re teaming up with Avidity Biosciences, Inc. again as a part of our ongoing efforts to help break the cycle of poverty and increase community members’ access to education, basic needs, and economic opportunity. The Avidity team is donating $250,000 through our Life Science Shares program to bolster our 2024 grantmaking portfolio and support volunteer programs to reduce the devastating impact of poverty and inequity throughout San Diego. Further demonstrating Avidity’s commitment to our community, they invited San Diego’s Monarch School students to tour Avidity’s lab space, connect with CEO Sarah Boyce, and practice networking with life science professionals. Through our collaborative efforts, we aim to foster educational opportunities and empower the future leaders in our community toward a brighter future. Check out this compelling video to see Life Science Shares' impact in action: https://lnkd.in/eTJtcSdh
-
As we celebrate #WomensEquality day, we wish to recognize the remarkable achievements of women within our company and across the #biotech industry. At Avidity, our #BeAVID culture champions gender equality, diversity, and inclusivity, ensuring that diverse voices and perspectives are valued and integrated into every facet of our work. Under the leadership of our CEO Sarah Boyce, we are proud that 58% of our workforce is comprised of women, and we are dedicated to empowering women to grow, thrive, and lead. Join us in recognizing and celebrating the invaluable contributions of women that continue to shape an inclusive future where everyone has equal opportunity to excel.
-
-
Meet Aide Gomez, our summer intern in Technical Development & Operations, currently studying #PublicHealth with a focus on Medical Sciences at UC San Diego. As a first-generation student passionate about addressing health disparities in communities, she is excited to be part of the #BeAVID team, where she sees an opportunity to further Avidity’s mission and contribute to advancing RNA therapeutics to improve people's lives. Learn more about our work at Avidity at https://lnkd.in/dH-56XKM
-
-
Last week, we welcomed students from the “Girls Who Lead” summer camp, a program that provides underrepresented high school students a unique opportunity to explore STEAM fields firsthand. As part of our ongoing partnership with Generation STEAM and Biocom, these students had the opportunity to meet our team and explore our labs, discovering how we leverage STEAM to innovate RNA therapeutics and positively impact patients and families affected by rare muscle disorders. We extend our thanks to each of the students from the “Girls Who Lead” summer camp for spending time with our team this past week, and to Biocom California for their continued partnership. It was an honor to share our experiences and inspire future leaders in the biotech sector.
-
-
#ICYMI In a recent Drug Development & Delivery article, our Distinguished Scientist and Strategic Leader, Art Levin, PhD, explores our efforts to develop a new class of RNA therapeutics called AOCs. A rapidly growing body of evidence reinforces the significant promise of AOCs to address many areas of unmet need in health in entirely new ways, starting with skeletal muscle diseases. At Avidity, we're harnessing our proprietary AOC platform to advance clinical programs targeting three rare muscle disorders: myotonic dystrophy type 1 (#DM1), Duchenne muscular dystrophy (#DMD), and facioscapulohumeral muscular dystrophy (#FSHD). Our early results with AOC technology highlight its ability to target diverse rare muscle disorders, positioning us as leaders in this cutting-edge field of innovation. Read the full article and learn about our recent milestones in all three programs: https://lnkd.in/eq-MCCVf
-